Website stats for Tri-kobe - tri-kobe.org
tri-kobe.org was registered 2 decades 1 year ago. It has a alexa rank of #4,207,575 in the world. It is a domain having .org extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, tri-kobe.org is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 208 |
| Daily Pageviews: | 416 |
Estimated Valuation
| Income Per Day: | $ 1.00 |
| Estimated Worth: | $ 240.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 4,207,575 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
202.70.140.2
Hosted Country:
JP
Location Latitude:
34.69Location Longitude:
135.196Traffic Classification
| Total Traffic: | 71.78K |
| Direct Traffic: | 15.79% |
| Referral Traffic: | 2.92% |
| Search Traffic: | 81.12% |
| Social Traffic: | 0% |
| Mail Traffic: | 0.18% |
| Display Traffic: | 0% |
Search Engine Results For tri-kobe.org
Breast Cancer
15 Jul 2020 ... NCCN.org. NCCN Guidelines for Patients® available at www.nccn.org/patients ... neoadjuvant chemotherapy for triple-negative breast cancer.
Occult Primary
Participation in clinical trials is especially encouraged. To find clinical trials online at NCCN. Member Institutions, click here: · nccn.org/clinical_trials/ ...
(NCCN Guidelines®) - Non-Small Cell Lung Cancer
11 Feb 2020 ... 4D-CT and/or PET/CT simulation, IMRT/VMAT, IGRT, motion management, and proton therapy (https://www.astro.org/Daily-Practice/.
Ovarian Cancer
NCCN Guidelines for Patients® available at www.nccn.org/patients ... carcinoma or triple-negative breast cancer: a phase 2, multicentre,.
(NCCN Guidelines®) - Prostate Cancer
19 Oct 2018 ... NCCN Guidelines for Patients® available at www.nccn.org/patients ... high-risk prostate cancer treated primarily with a triple modality ...
Occult Primary
nccn.org/clinical_trials/physician.html. NCCN Categories of Evidence and ... triple drug combination of paclitaxel, carboplatin, and oral etoposide.
NCCN: Genetic/Familial High-Risk Assessment: Breast and Ovarian
nccn.org/clinical_trials/clinicians.aspx. NCCN Categories of Evidence and ... >Triple-negative (ER-, PR-, HER2-) breast cancer diagnosed age ≤60 y. > ...
Cervical Cancer
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cervical Cancer. Version 4.2019 — March 29, 2019. Continue. NCCN.org ...
(NCCN) Guideline for Prostate Cancer Early Detection
31 May 2019 ... The complete details of the Development and Update of the NCCN. Guidelines are available on the NCCN website (www.NCCN.org). Types of Early ...
Kidney Cancer
16 Feb 2019 ... NCCN Guidelines for Patients® available at www.nccn.org/patients. Version 1.2021, 07/15/20 © 2020 National Comprehensive Cancer Network® ...
TRI 医療イノベーション推進センター [公益財団法人 神戸医療産業 ...
医療イノベーション推進センター（TRI）は神戸医療産業都市構想に基づき、基礎研究から臨床応用の橋渡し研究（トランスレーショナルリサーチ）を推進するための情報 ...
Translational Research Informatics Center (TRI) - Amazon AWS
- http://s3-service-broker-live-19ea8b98-4d41-4cb4-be4c-d68f4963b7dd.s3.amazonaws.com/uploads/ckeditor/attachments/8326/TRi.pdf
its establishment, the TRI has led academic translational research and conducted clinical studies (http://www.tri-kobe.org/). The TRI has.
を全面リニューアルしました！－ 世界最新のがん情報を配信 - 神戸市
7 Jul 2020 ... http://cancerinfo.tri-kobe.org/（外部リンク）. トップページからサイト内を横断的に検索できます！ イメージ図1. イメージ図2.
Association of Endocrine Therapy With Overall Survival in Women ...
24 Aug 2020 ... Accessed July 21, 2020. https://www2.tri-kobe.org/nccn/guideline/breast/english/breast.pdf. 5. Vaz-Luis I, Ottesen RA, Hughes ME, et al.
Association of Independent Prognostic Factors and Treatment ...
9 Jul 2020 ... ... treated vs untreated patients with triple-negative breast cancer; ... https://www2.tri-kobe.org/nccn/guideline/breast/english/breast.pdf.
Combination treatment options for small-cell lung cancer - The Lancet
22 Mar 2021 ... www2.tri-kobe.org/nccn/guideline/lung/ english/small.pdf (accessed Jan 29, 2021). 3 Früh M, De Ruysscher D, Popat S, et al.
TRI Terms of Service and Privacy Policy | NAN-BYO Research
NAN-BYO Research is published and administered for TRI by Nature Research Custom Media, part of Springer ... +81-78-303-9095 [email protected].
ABC Dementia Scale (ABC-DS) - ePROVIDE
Please contact [email protected]. Bibliographic reference(s) of the original questionnaire. Kikuchi T, Mori T, Wada-Isoe J, Umeda-Kameyama Y, ...
Tri-kobe.org View Learning
Learning in Tri-kobe.org. View learning learn education course research study Tri-kobe.org. Learning online now.
Translational Research Informatics Center (TRI) - Nature
- http://media.nature.com/full/nature-cms/uploads/ckeditor/attachments/7740/2017-10-26_Nat._Outline_Non-union_bone_fracture.pdf
www.tri-kobe.org. Transplantation of CD34+ cells for patients ... Center (TRI) was founded in 2002 as the ... network was established in 2013 by TRI and.
Deducing Multidecadal Anthropogenic Global Warming Trends ...
Zhou, Bin3 [email protected]. Ding, Ding2. Teramukai, Satoshi4. Guo, Qihao1,2. Fukushima, Masanori3. Hong, Zhen1,2 [email protected]
Breast Cancer Risk Reduction
23 Apr 2018 ... Continue. NCCN.org ... nccn.org/clinical_trials/clinicians.aspx. ... for luminal, HER2-overexpressing, and triple-negative breast cancer in.
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | 4 |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 24 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-6801187-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| 交通アクセス お問い合わせ | 3 | 3.947 % | No |
| 寄附について 採用情報 | 3 | 3.947 % | No |
| 事業の成果について 広報活動 | 2 | 2.632 % | No |
| プレスリリース 取材の申込み | 2 | 2.632 % | No |
| 広報活動 パンフレット・出版物 | 2 | 2.632 % | No |
| 事業の成果 事業の成果について | 2 | 2.632 % | No |
| 支援ツール 関連法規リンク集 | 2 | 2.632 % | No |
| 研究相談 研究支援 | 2 | 2.632 % | No |
| 研究支援 支援ツール | 2 | 2.632 % | No |
| 取材の申込み イベント案内 | 2 | 2.632 % | No |
| 関連法規リンク集 事業の成果 | 2 | 2.632 % | No |
| TRI支援研究ポータルサイト がん情報サイト | 2 | 2.632 % | No |
| Orphanet Japan | 2 | 2.632 % | No |
| 20210802 ニュース | 2 | 2.632 % | No |
| RESEARCH from | 2 | 2.632 % | No |
| Transfert SA | 2 | 2.632 % | No |
| 特許Inserm Transfert | 2 | 2.632 % | No |
| 研究体制 研究相談 | 2 | 2.632 % | No |
| Translational Research | 2 | 2.632 % | No |
| Research Center | 2 | 2.632 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Center for Medical Innovation | 2 | 2.632 % | No |
| Translational Research Center for | 2 | 2.632 % | No |
| Research Center for Medical | 2 | 2.632 % | No |
| 研究体制 研究相談 研究支援 支援ツール | 2 | 2.632 % | No |
| © Translational Research Center | 1 | 1.316 % | No |
| Copyright © Translational Research | 1 | 1.316 % | No |
| for Medical Innovation All | 1 | 1.316 % | No |
| Medical Innovation All Rights | 1 | 1.316 % | No |
| Reserved | 1 | 1.316 % | No |
| Rights Reserved | 1 | 1.316 % | No |
| All Rights Reserved | 1 | 1.316 % | No |
| Innovation All Rights Reserved | 1 | 1.316 % | No |
| NANBYO RESEARCH from JAPAN | 1 | 1.316 % | No |
| PICK UP コンテンツ TRIについて | 1 | 1.316 % | No |
| Orphanet Japan 関連リンク NEWS | 1 | 1.316 % | No |
| SA Orphanet Japan 関連リンク | 1 | 1.316 % | No |
| Transfert SA Orphanet Japan | 1 | 1.316 % | No |
| 特許Inserm Transfert SA Orphanet | 1 | 1.316 % | No |
| Japan 関連リンク NEWS 新着情報 | 1 | 1.316 % | No |
| 関連リンク NEWS 新着情報 20210827 | 1 | 1.316 % | No |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Server: nginx
Date: Mon, 30 Aug 2021 00:08:00 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding,User-Agent
X-FRAME-OPTIONS: sameorigin
X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
X-Permitted-Cross-Domain-Policies: master-only
Strict-Transport-Security: max-age=31536000
Content-Security-Policy: upgrade-insecure-requests
Content-Encoding: gzip
Domain Information
| Domain Registrar: |
Public Interest Registry
|
|---|---|
| Registration Date: | 2002-10-09 2 decades 1 year 11 months ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.tri-kobe.org | |
202.70.140.2 | Japan |
| trihime.tri-kobe.org | |
202.70.140.3 | Japan |
| dns-x.sinet.ad.jp | |
150.100.18.6 | Japan |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| tri-kobe.org | A | 28668 |
IP: 202.70.140.2 |
| tri-kobe.org | NS | 28800 |
Target: dns-x.sinet.ad.jp |
| tri-kobe.org | NS | 28800 |
Target: trihime.tri-kobe.org |
| tri-kobe.org | NS | 28800 |
Target: ns1.tri-kobe.org |
| tri-kobe.org | NS | 28800 |
Target: nsnet1.tri-kobe.net |
| tri-kobe.org | SOA | 28800 |
MNAME: ns1.tri-kobe.org RNAME: postmaster.tri-kobe.org Serial: 2021021003 Refresh: 28800 Retry: 7200 Expire: 604800 |
| tri-kobe.org | MX | 28800 |
Priority: 30 Target: nsnet1.tri-kobe.net |
| tri-kobe.org | MX | 28800 |
Priority: 20 Target: trihime.tri-kobe.org |
| tri-kobe.org | MX | 28800 |
Priority: 10 Target: ns1.tri-kobe.org |
| tri-kobe.org | TXT | 28800 |
TXT: MS=ms27956460 |
| tri-kobe.org | TXT | 28800 |
TXT: v=spf1 +ip4:202.70.140.3 +ip4:202.70.140.2 +ip4:180.42.102.2 ~all |
Top Organic Keyword
| 1. | アルツハイマー病 |
| 2. | アルツハイマー |
| 3. | cervical cancer nccn |
| 4. | non small cell lung cancer nccn guidelines |
| 5. | nccn |
Top Paid Keyword
| Not Applicable |
Top Referral Site
| 1. | fbri-kobe.org |
| 2. | ganjoho.jp |
| 3. | jpn-geriat-soc.or.jp |
| 4. | jnets.umin.jp |
Top Destination Site
| 1. | cancer.gov |
| 2. | nci-media.cancer.gov |
| 3. | google.co.jp |
Full WHOIS Lookup
Registry Domain ID:
D91038706-LROR
Registrar WHOIS Server:
whois.discount-domain.com
Registrar URL:
www.onamae.com
Updated Date: 2019-07-30T02:35:07Z
Creation
Date: 2002-10-09T05:19:23Z
Registry Expiry Date:
2022-10-09T05:19:23Z
Registrar Registration Expiration
Date:
Registrar: GMO Internet, Inc. d/b/a Onamae.com
Registrar
IANA ID: 49
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+81.337709199
Reseller:
Domain Status: ok
https://icann.org/epp#ok
Registrant Organization: Foundation for
Biomedical Research and Innovation
Registrant State/Province:
Hyogo
Registrant Country: JP
Name Server:
NS1.TRI-KOBE.ORG
Name Server: TRIHIME.TRI-KOBE.ORG
Name
Server: DNS-X.SINET.AD.JP
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form https://www.icann.org/wicf/)
>>>
Last update of WHOIS database: 2021-08-30T00:07:08Z
Similarly Ranked Websites
Palinsesto tv , guida ai programmi tv digitale terrestre dtt di Rai...
Il palinsesto dei programmi di oggi, stasera in tv su Rai, Mediaset, Mediaset Premium, Sky, Giallo, Iris, Cielo, La 7, Dmax, Focus
4,207,601 
$ 240.00
Eiferer Smart Home - Automation with Sonoff products — Eiferer_ZA
Home automation with sonoff products, wifi smart switches and voice controlled devices. Smart home with sonoff remote control, automate, monitor home devices like lights,...
4,207,636 $ 240.00
GenVideos
GenVideos - Free Movies. Watch Movies Online free, in high quality. Watch latest movies in HD for free, free movies streaming online, most 2019
4,207,667 $ 240.00